Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 30, 2019
Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients
M E S Smith-Uffen, S B Johnson, A J Martin, et al.
British Journal of Cancer
|
April 10, 2014
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
H-M Lin, L Castillo, K L Mahon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
P S Grimison, M R Stockler, M Chatfield, et al.
Gynecologic Oncology
|
December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)
F T Roncolato, R L O'Connell, F Joly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
I D Davis, A Long, S Yip, et al.
British Journal of Cancer
|
April 14, 2015
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
K L Mahon, H-M Lin, L Castillo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
S A Laurie, B J Solomon, L Seymour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2015
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
A Davidson, A-S Veillard, A Tognela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)
H-M Lin, T Scheinberg, N Portman, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 30, 2019
Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients
M E S Smith-Uffen, S B Johnson, A J Martin, et al.
British Journal of Cancer
|
April 10, 2014
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
H-M Lin, L Castillo, K L Mahon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
P S Grimison, M R Stockler, M Chatfield, et al.
Gynecologic Oncology
|
December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)
F T Roncolato, R L O'Connell, F Joly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
I D Davis, A Long, S Yip, et al.
British Journal of Cancer
|
April 14, 2015
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
K L Mahon, H-M Lin, L Castillo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
S A Laurie, B J Solomon, L Seymour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2015
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
A Davidson, A-S Veillard, A Tognela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)
H-M Lin, T Scheinberg, N Portman, et al.
Page
of 5